Compared with SGLT-2 inhibitors, GLP-1 receptor agonists were linked to a 37% higher risk of alopecia
Introduction Gastrointestinal hormones, such as ghrelin and glucagon-like peptide-1 (GLP-1), control various functions within the digestive system while communicating with our central nervous system (CNS) as part of the gutbrain axis
While most are approved for the management of type 2 diabetes, some formulations, such as semaglutide (Wegovy) and tirzepatide (Zepbound), have also been approved for chronic weight management in adults with obesity or overweight
Coverage may include medical evaluations for obesity, GLP-1 prescription medication management, and follow-up appointments, depending on your specific plan, deductible status, formulary, and eligibility criteria